209 related articles for article (PubMed ID: 16779709)
1. Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.
Castella ME; Reist M; Mayer JM; Turban JJ; Testa B; Boursier-Neyret C; Walther B; Delbos JM; Carrupt PA
Pharm Res; 2006 Jul; 23(7):1543-53. PubMed ID: 16779709
[TBL] [Abstract][Full Text] [Related]
2. Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion.
Lozoya-Agullo I; Zur M; Beig A; Fine N; Cohen Y; González-Álvarez M; Merino-Sanjuán M; González-Álvarez I; Bermejo M; Dahan A
Int J Pharm; 2016 Dec; 515(1-2):201-208. PubMed ID: 27667756
[TBL] [Abstract][Full Text] [Related]
3. Absorption barriers in the rat intestinal mucosa: 1. Application of an in situ perfusion model to simultaneously assess drug permeation and metabolism.
Mudra DR; Borchardt RT
J Pharm Sci; 2010 Feb; 99(2):982-98. PubMed ID: 19746412
[TBL] [Abstract][Full Text] [Related]
4. Single-pass intestinal perfusion to establish the intestinal permeability of model drugs in mouse.
Escribano E; Sala XG; Salamanca J; Navarro CR; Regué JQ
Int J Pharm; 2012 Oct; 436(1-2):472-7. PubMed ID: 22814225
[TBL] [Abstract][Full Text] [Related]
5. Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model.
Wahajuddin ; Singh SP; Patel K; Pradhan T; Siddiqui HH; Singh SK
Arzneimittelforschung; 2011; 61(9):532-7. PubMed ID: 22029231
[TBL] [Abstract][Full Text] [Related]
6. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches.
Lozoya-Agullo I; Zur M; Wolk O; Beig A; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A
Int J Pharm; 2015 Mar; 480(1-2):1-7. PubMed ID: 25595387
[TBL] [Abstract][Full Text] [Related]
7. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
[TBL] [Abstract][Full Text] [Related]
8. Suitability of isolated rat jejunum model for demonstration of complete absorption in humans for BCS-based biowaiver request.
Peternel L; Kristan K; Petruševska M; Rižner TL; Legen I
J Pharm Sci; 2012 Apr; 101(4):1436-49. PubMed ID: 22234826
[TBL] [Abstract][Full Text] [Related]
9. Comparison between permeability coefficients in rat and human jejunum.
Fagerholm U; Johansson M; Lennernäs H
Pharm Res; 1996 Sep; 13(9):1336-42. PubMed ID: 8893271
[TBL] [Abstract][Full Text] [Related]
10. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
[TBL] [Abstract][Full Text] [Related]
11. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.
Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A
Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412
[TBL] [Abstract][Full Text] [Related]
12. The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum.
Sandström R; Karlsson A; Lennernäs H
J Pharm Pharmacol; 1998 Jul; 50(7):729-35. PubMed ID: 9720621
[TBL] [Abstract][Full Text] [Related]
13. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats.
Sandström R; Lennernäs H
Drug Metab Dispos; 1999 Aug; 27(8):951-5. PubMed ID: 10421625
[TBL] [Abstract][Full Text] [Related]
14. Predicting human intestinal permeability using single-pass intestinal perfusion in rat.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Azarmi Y; Islambolchilar Z; Barzegar S; Barzegar-Jalali M
J Pharm Pharm Sci; 2007; 10(3):368-79. PubMed ID: 17727800
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion.
Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
Biol Pharm Bull; 2010; 33(1):111-6. PubMed ID: 20045946
[TBL] [Abstract][Full Text] [Related]
16. Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil.
Estudante M; Maya M; Morais JG; Soveral G; Benet LZ
Mol Pharm; 2013 Nov; 10(11):4038-45. PubMed ID: 24044638
[TBL] [Abstract][Full Text] [Related]
17. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.
Dahan A; West BT; Amidon GL
Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572
[TBL] [Abstract][Full Text] [Related]
18. Intestinal permeability of forskolin by in situ single pass perfusion in rats.
Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY
Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728
[TBL] [Abstract][Full Text] [Related]
19. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.
Li H; Jin HE; Shim WS; Shim CK
Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579
[TBL] [Abstract][Full Text] [Related]
20. In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model.
Lozoya-Agullo I; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M
J Pharm Sci; 2015 Sep; 104(9):3136-45. PubMed ID: 25891783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
